^
No biomarker
Penile Cancer
paclitaxel
Sensitive
:
A2
No biomarker
Penile Cancer
capecitabine
Sensitive
:
A2
No biomarker
Penile Cancer
cetuximab
Sensitive
:
A2
No biomarker
Penile Cancer
cisplatin
Sensitive
:
A2
No biomarker
Penile Cancer
5-fluorouracil + mitomycin-c
Sensitive
:
A2
No biomarker
Penile Cancer
carboplatin + paclitaxel
Sensitive
:
A2
No biomarker
Penile Cancer
cisplatin + irinotecan
Sensitive
:
A2
No biomarker
Penile Cancer
cisplatin + 5-fluorouracil
Sensitive
:
A2
No biomarker
Penile Cancer
imiquimod
Sensitive
:
A2
No biomarker
Penile Cancer
5-fluorouracil
Sensitive
:
A2
No biomarker
Penile Cancer
TIP
Sensitive
:
A2
MSI-H/dMMR
Penile Cancer
pembrolizumab
Sensitive
:
A2
TMB-H
Penile Cancer
pembrolizumab
Sensitive
:
C1
PD-L1 expression
Penile Cancer
pembrolizumab
Sensitive
:
C1
TMB-H + PD-L1 expression + MSI-L/dMMR
Penile Cancer
nivolumab + ipilimumab
Sensitive
:
C4
TMB-H + PD-L1 expression
Penile Cancer
toripalimab
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our